???global.info.a_carregar???
Identification

Personal identification

Full name
Ana Marta Matos Silva

Citation names

  • Silva, Ana-Marta

Author identifiers

Ciência ID
F61C-2436-0DD4
ORCID iD
0000-0003-2355-2310

Email addresses

  • ammsilva@med.up.pt (Professional)
Education
Degree Classification
2015/12/16 - 2021/07/30
Ongoing
 Investigação Clínica e em Serviços de Saúde (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2007/09/24 - 2012/10/16
Concluded
 Ciências Farmacêuticas (Mestrado integrado)
Instituto Universitário de Ciências da Saúde, Portugal
Affiliation

Science

Category
Host institution 		Employer
2014/01/01 - Current Researcher (Research) Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Other Careers

Category
Host institution 		Employer
2013/04/01 - Current Técnico Superior (Técnico Superior) Universidade do Porto Faculdade de Medicina, Portugal
Outputs

Publications

Book
  1. Rodrigues, P.P.; Ferreira-Santos, D.; Silva, A.; Polónia, J.; Ribeiro-Vaz, I.. Implementing guidelines for causality assessment of adverse drug reaction reports: A Bayesian network approach. 2017.
    10.1007/978-3-319-59758-4_6
Book chapter
  1. Silva, Ana-Marta. "Unidade de Farmacovigilância do Porto". In Farmacovigilância em Portugal: 25 anos, 105-115. Portugal, 2018.
    Published
  2. Ribeiro-Vaz, Inês; Silva, Fabrício Alves Barbosa; Silva, Ana-Marta Matos; Alves, Domingos; Cruz-Correia, Ricardo. "Pharmacovigilance Informatics". In Encyclopedia of E-Health and Telemedicine, 299-315. IGI Global, 2016.
    10.4018/978-1-4666-9978-6.ch025
Conference abstract
  1. Silva, Ana-Marta. "Current Status of Risk-Sharing Agreements in Portuguese Health Care System: Preliminary Results". Paper presented in Conference Proceedings for the Fourth International Forum on Quality Cancer Care (IFQCC2020) April 4 and 5, 2020, Abstracts, Queens College, Oxford University, Oxford, UK, Oxford, 2020.
    Published • https://doi.org/10.4103/i2589-9449-3.5.S1
Conference paper
  1. Silva, Ana-Marta. "Strategies for detection adverse drug reactions - comparison of hospital database and spontaneous reporting". Paper presented in 15th ISoP Annual Meeting “Cubism in Pharmacovigilance, 2015.
Conference poster
  1. Silva, Ana-Marta. "Notificação de RAM por utentes em Portugal: 6 anos de experiência". Paper presented in "Inovação em Farmacovigilância” organizado pelo INFARMED, I.P., 2018.
  2. Silva, Ana-Marta. "Multicentric prospective observational study evaluating subcutaneous trastuzumab toxicity in non-metastatic breast cancer patients". Paper presented in MASCC/ISOO 2017 Annual Meeting on Supportive Care in Cancer, 2017.
Journal article
  1. Ivos, R.; Ribeiro-Vaz, I.; Polónia, J.; Silva, A.. "PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System". Value in Health 24 (2021): S90. http://dx.doi.org/10.1016/j.jval.2021.04.465.
    10.1016/j.jval.2021.04.465
  2. Silva, Ana-Marta. "The Role of Pharmacovigilance in the COVID-19 Pandemic". Acta medica portuguesa (2021): https://doi.org/10.20344/amp.15375.
    10.20344/amp.15375
  3. Silva, A.. "PNS48 ADR Report By Consumers in Portugal: 8 YEARS of Experience". Value in Health 23 (2020): S652. http://dx.doi.org/10.1016/j.jval.2020.08.1492.
    10.1016/j.jval.2020.08.1492
  4. Silva, Ana-Marta. "Real-world evidence in antiretroviral therapy: drug safety data". The Brazilian Journal of Infectious Diseases (2020): http://dx.doi.org/10.1016/j.bjid.2020.04.013.
    10.1016/j.bjid.2020.04.013
  5. Rodrigues, P.P.; Ferreira-Santos, D.; Silva, A.; Polónia, J.; Ribeiro-Vaz, I.. "Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network". Artificial Intelligence in Medicine 91 (2018): 12-22. http://www.scopus.com/inward/record.url?eid=2-s2.0-85050865995&partnerID=MN8TOARS.
    10.1016/j.artmed.2018.07.005
  6. Ribeiro-Vaz, I.; Silva, A.-M.; Costa Santos, C.; Cruz-Correia, R.. "How to promote adverse drug reaction reports using information systems - A systematic review and meta-analysis". BMC Medical Informatics and Decision Making 16 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84966415619&partnerID=MN8TOARS.
    10.1186/s12911-016-0265-8
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2019 Notification of ADR by patients and informal caregivers Pharm+V - ONCO Pharmacovigilance Conference
(Portugal)
2017 Farmacovigilância: Segurança do doente Ensaios Clínicos: Desafios também para os Farmacêuticos - Jornadas de Ciências Farmacêuticas do Instituto Universitário de Ciências da Saúde
(Porto, Portugal)